A new mouse model highlights the need for better JAK inhibitors in myeloproliferative neoplasms

Hemasphere. 2024 Apr 2;8(4):e66. doi: 10.1002/hem3.66. eCollection 2024 Apr.

Author

Charles E de Bock^{1

2}

Affiliations

¹ Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia.
² School of Clinical Medicine UNSW Sydney Kensington New South Wales Australia.

No abstract available

Publication types

Editorial